Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 13/20 | 0.39 |
| ▸ | CA2 | P00918 | 13/20 | 0.39 |
| ▸ | EYA2 | O00167 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | MVD | P53602 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Creatine SCHEMBL21567 | 0.98 | — | — | |
| Creatine SCHEMBL4007614 | 0.98 | NOS3 (0.46) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL27979093 | 0.98 | NOS3 (0.46) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL30063981 | 0.98 | — | — | |
| Creatine SCHEMBL5568320 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL21810557 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL2774044 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL21404054 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL20497169 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 | |
| Creatine SCHEMBL675799 | 0.95 | NOS3 (0.44) | NOS3NOS1NOS2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023096267-A1 | METHOD AND DEVICE FOR ESTIMATING DIABETIC NEPHROPATHY | 고려대학교 산학협력단 | 2023-06-01 | — | — | WO | disclosed |
| EP-0978568-B1 | Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity | BAYER AG (US) | 2004-09-29 | — | — | EP | disclosed |
| US-6074881-A | TEST FOR THE ACTIVITY OF A METAL CHELATE IN A FLUID SAMPLE; FOR THE DETECTION OF CREATININE IN A URINE SAMPLE | BAYER CORPORATION (US) | 2000-06-13 | — | — | US | disclosed |
| EP-0978568-A2 | Method for the prevention of hemoglobin interference in reagent systems for measuring peroxidase activity | Bayer Corporation (US) | 2000-02-09 | — | — | EP | disclosed |